These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31677794)

  • 21. Filling the drug discovery gap: is high-content screening the missing link?
    Dorval T; Chanrion B; Cattin ME; Stephan JP
    Curr Opin Pharmacol; 2018 Oct; 42():40-45. PubMed ID: 30032033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-impedance-based label-free technology for the identification of new drugs.
    Lundstrom K
    Expert Opin Drug Discov; 2017 Apr; 12(4):335-343. PubMed ID: 28276704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next-Generation Compound Delivery Platforms to Support Miniaturized Biology.
    Bhatt S; Crimmin S; Gross J; Nixon E; Truong M; Weglos M; Kallal L
    SLAS Technol; 2019 Jun; 24(3):245-255. PubMed ID: 30726680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomechanically primed liver microtumor array as a high-throughput mechanopharmacological screening platform for stroma-reprogrammed combinatorial therapy.
    Zhu L; Fan X; Wang B; Liu L; Yan X; Zhou L; Zeng Y; Poznansky MC; Wang L; Chen H; Du Y
    Biomaterials; 2017 Apr; 124():12-24. PubMed ID: 28182873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfection microarrays for high-throughput phenotypic screening of genes involved in cell migration.
    Onuki-Nagasaki R; Nagasaki A; Hakamada K; Uyeda TQ; Fujita S; Miyake M; Miyake J
    Methods Mol Biol; 2010; 629():193-203. PubMed ID: 20387151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FLECS Technology for High-Throughput Single-Cell Force Biology and Screening.
    Pushkarsky I
    Assay Drug Dev Technol; 2018 Jan; 16(1):7-11. PubMed ID: 29266960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening.
    Eglen R; Reisine T
    Assay Drug Dev Technol; 2011 Apr; 9(2):108-24. PubMed ID: 21186936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
    Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA
    J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing a novel fiber optic fluorescence device for multiplexed high-throughput cytotoxic screening.
    Lee D; Barnes S
    J Exp Ther Oncol; 2010; 8(3):235-45. PubMed ID: 20734922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
    Clements M; Millar V; Williams AS; Kalinka S
    Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EphB4 cellular kinase activity assayed using an enzymatic protein interaction system.
    Wehrman T; Nguyen M; Feng W; Bader B
    Assay Drug Dev Technol; 2013 May; 11(4):237-43. PubMed ID: 23557019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
    Miller TW; Amason JD; Garcin ED; Lamy L; Dranchak PK; Macarthur R; Braisted J; Rubin JS; Burgess TL; Farrell CL; Roberts DD; Inglese J
    PLoS One; 2019; 14(7):e0218897. PubMed ID: 31276567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-Based Assay Design for High-Content Screening of Drug Candidates.
    Nierode G; Kwon PS; Dordick JS; Kwon SJ
    J Microbiol Biotechnol; 2016 Feb; 26(2):213-25. PubMed ID: 26428732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technologies for transporter drug discovery.
    Weinglass AB; Garcia ML; Kaczorowski GL
    Channels (Austin); 2008; 2(5):312-21. PubMed ID: 18989100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues.
    Drewitz M; Helbling M; Fried N; Bieri M; Moritz W; Lichtenberg J; Kelm JM
    Biotechnol J; 2011 Dec; 6(12):1488-96. PubMed ID: 22102438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of high-throughput screening.
    Entzeroth M; Flotow H; Condron P
    Curr Protoc Pharmacol; 2009 Mar; Chapter 9():Unit 9.4. PubMed ID: 22294406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A High Throughput Apoptosis Assay using 3D Cultured Cells.
    Lee SY; Doh I; Lee DW
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31527418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogel tissue construct-based high-content compound screening.
    Lam V; Wakatsuki T
    J Biomol Screen; 2011 Jan; 16(1):120-8. PubMed ID: 21123829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.